CoreWeave acquisition at 0.1235 share exchange ratio
Company: Core Scientific
The claim, verbatim
CoreWeave will acquire Core Scientific in an all-stock transaction where each share of Core Scientific common stock will be converted into 0.1235 shares of CoreWeave Class A common stock, subject to stockholder approval at meeting on October 30, 2025
Source (primary)
core-scientific 8-K exhibit (q32025corescientificinc-ea.htm) (SEC EDGAR (8-K Ex), press_release)
View cached copy (2026-09-27)Live source ↗
Quote: “each outstanding share of the Company's common stock at the Effective Time (as defined in the Merger Agreement) would be cancelled and converted into a number of fully paid and non-assessable shares of CoreWeave Class A common stock, equal to the exchange ratio of 0.1235. The transaction is subject to the approval of the Company's stockholders at the Company's Special Meeting of Stockholders to be held virtually at 10:00 a.m. Eastern Time on October 30, 2025”
How we checked this
Checked on September 29, 2026. The cited source supports every part of this claim.
The earnings release states the all-stock deal terms, the 0.1235 exchange ratio into CoreWeave Class A shares, and the October 30, 2025 stockholder vote. It frames the deal as conditional ('if consummated') and also subject to other customary closing conditions.
Confirmed in the source:
- CoreWeave would acquire Core Scientific in an all-stock transaction under a Merger Agreement dated July 7, 2025
- Each outstanding share of Core Scientific common stock would be converted into CoreWeave Class A common stock at an exchange ratio of 0.1235
- The transaction is subject to approval by Core Scientific stockholders at a special meeting on October 30, 2025
What we did: Read our cached copy of SEC EDGAR (8-K Ex) (https://www.sec.gov/Archives/edgar/data/1839341/000162828025046263/q32025corescientificinc-ea.htm) in full (35,843 characters, retrieved September 27, 2026) and checked each assertion in the claim against it.
Additional evidence
confirms core-scientific 8-K exhibit (q32025corescientificinc-ea.htm)
Quote: “each outstanding share of the Company's common stock at the Effective Time (as defined in the Merger Agreement) would be cancelled and converted into a number of fully paid and non-assessable shares of CoreWeave Class A common stock, equal to the exchange ratio of 0.1235. The transaction is subject to the approval of the Company's stockholders at the Company's Special Meeting of Stockholders to be held virtually at 10:00 a.m. Eastern Time on October 30, 2025”